James O. Armitage

James O. Armitage is a declared insider at 2 companies (board member); the most frequent names are TESARO, Inc. and Cardiff Oncology, Inc. The record holds 9 filings, for trades running from 12 December 2014 to 16 September 2022.

On the open market, the record shows 5 purchases worth €126k and 2 sales worth €979k. Taken together, the sales exceed the purchases by €854k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 option exercise. Since January 2022: 1 purchase and no sales on the market.

In size, the median ticket on the buying side is €24k. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 11 October 2022, reports an open-market purchase of €20k in Cardiff Oncology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.